Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

AnaSpec Announces a Broad Selection of T-Cell Epitopes

Released on: January 21, 2008, 2:11 pm

Press Release Author: AnaSpec Inc.

Industry: Biotech

Press Release Summary: AnaSpec has announced the availability of a wide selection of
T-Cell Epitopes, available both individually and pooled.

Press Release Body: January 21, 2008 - San Jose, CA

Peptides, used individually, as pools or as libraries, have been used extensively as
vaccines in stimulating T cells.1 Once bound to MHC (major histocompatibility
complex) molecules, these T cells epitopes can activate CD4 or CD8 T cells.1, 2

AnaSpec has announced the availability of a wide selection of T-Cell Epitopes,
available both individually and pooled. Use of these peptides has been reported in
journals such as the Journal of Biological Chemistry since 1997.3

Company Info

AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents (dyes, assay kits, & antibodies), and
combinatorial chemistry.

For more information, visit www.anaspec.com

References:
1. Kiecker, F. et al. Human Immunol. 65, 523 (2004).
2. Robinson, JH. And AA. Delvig, Immunology 105, 252 (2002).
3. Ben-Shahar, S. et al. J. Biol. Chem. 272, 21060 (1997).
4. Sato, N. et al. Proc. Natl. Acad. Sci. 104, 588 (2007).
5. Galibert, L. et al. J. Biol. Chem. 280, 21955 (2005).
6. Komlosh, A. et al. J. Biol. Chem. 276, 30050 (2001).
7. Ben-Shahar, S. et al. J. Biol. Chem. 274, 21963 (1999).
8. Stachowiak, AN. et al. J. Immunol. 177, 2340 (2006).
9. Garrod, KR. et al. J. Immunol. 177, 863 (2006).
10. Baekkevold, ES. et al. J. Exp. Med. 201, 1045 (2005).
11. Kwa, S. et al. J. Immunol. 201, 1045 (2005).
12. Seroogy, CM. et al. J. Immunol. 173, 79 (2004).
13. Dorsam, G. et al. J. Immunol. 171, 3500 (2003).
14. Bard, F. et al. PNAS. 100, 2023 (2003).


Web Site: http://www.anaspec.com

Contact Details: AnaSpec Inc.
2149 O\'Toole Ave.
San Jose, CA 95129
ping@anaspec.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •